Gabapentin Capsule
Product Images NDC 50228-179

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50228-179). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin 100mg 1000s

Label for Gabapentin Capsules, USP 100 mg by ScieGen Pharmaceuticals, Inc. The label includes an NDC number, dispensing instructions, and storage conditions. It specifies that the bottle contains 1,000 capsules, meant for oral administration, and notes that this product is Rx only.*

FDA Label Image

Gabapentin 100mg 100s

Gabapentin 100 mg capsules label from ScieGen Pharmaceuticals, Inc. The label states 100 capsules per container, oral capsules, USP. It includes directions for pharmacists to provide a medication guide, prescription status (Rx only), storage instructions, and manufacturer information. The label also displays the NDC 50228-179-01 and a barcode.*

FDA Label Image

Gabapentin 100mg 30s

Label for Gabapentin Capsules, USP 100 mg by ScieGen Pharmaceuticals, Inc. The capsule contains 100 mg gabapentin. The label includes storage instructions, dosage advisory, packaging details, and a barcode. The package contains 30 capsules for prescription use only.*

FDA Label Image

Gabapentin 100mg 500cap

Label for Gabapentin Capsules, USP 100 mg by ScieGen Pharmaceuticals, Inc. The label indicates the product is prescription only and contains 500 capsules. The label includes dosage information, storage instructions, and a barcode. The dimensions 1.1" x 2.5" and note 'NO VARNISH' are also visible.*

FDA Label Image

Gabapentin 300mg 30s

Gabapentin Capsules, USP 300 mg, oral capsules in a package of 30 count by ScieGen Pharmaceuticals, Inc. The label includes dosage strength, storage information, and a barcode. It indicates Rx only and advises dispensing with a Medication Guide. The label also notes child-resistant container requirements and manufacturer details in Hauppauge, NY.*

FDA Label Image

Gabapentin 300mg 1000cap

Gabapentin Capsules, USP 300 mg oral dosage form in a packaging label displaying 1,000 capsules. The label includes the NDC code 50228-180-10 and is manufactured by ScieGen Pharmaceuticals, Inc. It features storage instructions and a barcode, with a prominent purple 300 mg strength indicator. The label is for Rx only use.*

FDA Label Image

Gabapentin 300mg 100cap

Gabapentin Capsules, USP 300 mg oral capsules, labeled for 100 count, by ScieGen Pharmaceuticals, Inc. The label includes storage instructions, dispensing guidelines, barcode, and the NDC number 50228-180-01. The packaging highlights 'NO VARNISH' and the capsule strength in a purple oval.*

FDA Label Image

Gabapentin Capsules, Usp 300 mg (500 capsules label)

Label for Gabapentin Capsules, USP 300 mg by ScieGen Pharmaceuticals, Inc. The label indicates prescription use with 500 capsules in the package. Storage instructions and dispensing warnings are included alongside the NDC 50228-180-05 and a barcode.*

FDA Label Image

Gabapentin 400mg 30s

Label for Gabapentin Capsules, USP 400 mg by ScieGen Pharmaceuticals, Inc. The label indicates each capsule contains 400 mg of gabapentin, with a package count of 30 capsules. Storage instructions and dispensing requirements are noted, along with a barcode and manufacturer information from ScieGen Pharmaceuticals, Inc., Hauppauge, NY.*

FDA Label Image

Gabapentin 400mg 100cap

Gabapentin Capsules USP 400 mg oral dosage form packaging label by ScieGen Pharmaceuticals, Inc. The label states the product name, strength, dosage form, and quantity of 100 capsules per bottle. Instructions for pharmacists regarding medication guides and storage conditions are included, along with manufacturing information and a barcode.*

FDA Label Image

Gabapentin Capsules, Usp 400 mg (500 capsules label)

Label for Gabapentin Capsules, USP 400 mg, oral dosage form by ScieGen Pharmaceuticals, Inc. The label indicates a package size of 500 capsules, prescription only. It includes dosage information, storage instructions, and a barcode, with dimensions noted as 1.5" x 3.0" and a 'No Varnish' print specification.*

FDA Label Image

Gabapentin 600mg 30s

Label for Gabapentin Tablets USP 600 mg oral tablets, manufactured by ScieGen Pharmaceuticals, Inc. The label includes storage instructions, dosage advisory to refer to prescribing information, and packaging details for a 30-tablet container. It features the NDC code 50228-177-30 and indicates Rx-only status.*

FDA Label Image

Gabapentin 600mg 100tab

Label for Gabapentin Tablets, USP 600 mg by ScieGen Pharmaceuticals, Inc. The label indicates the product contains 100 tablets and includes directions for pharmacists to provide a medication guide. Additional information includes dosing, storage instructions, and caution to keep medication out of reach of children.*

FDA Label Image

Gabapentin Tablets, Usp 600 mg (500 Tablets label)

Label for Gabapentin Tablets, USP 600 mg oral tablets by ScieGen Pharmaceuticals Inc. The label indicates 500 tablets, Rx only, with directions to provide a medication guide to patients. Storage instructions and barcode are included. The label size is noted as 1.5 by 3.0 inches with no varnish.*

FDA Label Image

Gabapentin 800mg 30s

Gabapentin Tablets, USP 800 mg oral tablets label indicating 30 tablets per container, manufactured by ScieGen Pharmaceuticals, Inc. The label includes storage instructions (20° to 25°C), a barcode, and dosing advisory to read accompanying prescribing information. It specifies dispensing in a child-resistant container and includes the NDC number 50228-178-30.*

FDA Label Image

Gabapentin 800mg 100tab

Gabapentin Tablets, USP 800 mg oral dosage form label by ScieGen Pharmaceuticals, Inc. The label indicates it contains 100 tablets, prescription only. It includes dosing and storage instructions along with manufacturer details. The label features a barcode and a space measuring 1.0" x 2.0" labeled 'NO VARNISH.'*

FDA Label Image

Gabapentin Tablets, Usp 800 mg (500 Tablets label)

Packaging label for Gabapentin Tablets, USP 800 mg by ScieGen Pharmaceuticals, Inc. The label indicates each bottle contains 500 tablets. It includes dosing information, storage instructions, barcode, and the directive to provide a Medication Guide to patients.*

FDA Label Image

Image 01

A line graph depicting mean pain scores over an 8-week period comparing placebo and Gabapentin at 3600 mg/day. The x-axis represents weeks, including baseline, and the y-axis shows mean pain scores from 0 to 10. Two periods are indicated: a 4-week dose titration followed by a 4-week fixed dose. The Gabapentin group shows a downward trend in pain scores, while the placebo group remains relatively stable.*

FDA Label Image

Image 02

A line graph displaying mean pain scores over a 7-week period comparing placebo and Gabapentin dosed at 1800 mg/day and 2400 mg/day. The x-axis represents weeks, divided into a 3-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain score values ranging from 0 to 10.*

FDA Label Image

Image 03

A bar chart titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' showing data from two studies. The chart compares placebo (PBO) and gabapentin (GBP) dosages in mg, with proportions of responders labeled as percentages on each bar. Study 1 includes PBO and GBP 3600, Study 2 includes PBO, GBP 1800, and GBP 2400, indicating higher response rates for gabapentin groups. Statistical significance is noted by asterisks with p-values below 0.01 and 0.001.*

FDA Label Image

Cockcroft And Gault Equation (Image 04)

A formula panel showing the equation for calculating creatinine clearance (CLCr). The equation includes variables for age in years, weight in kilograms, and serum creatinine in mg/dL, with a multiplication factor of 0.85 for female patients. This is a typical clinical pharmacokinetic parameter calculation.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of gabapentin, showing its molecular arrangement with a cyclohexane ring attached to amino and carboxyl functional groups.*

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Image 09)

A scatter plot showing the percentage difference versus daily dose in milligrams, with data points labeled as Study a, Study b, and Study c. The x-axis represents the daily dose ranging approximately from 600 mg to 1800 mg, and the y-axis shows the percentage difference from about 2% to 22%. Different markers distinguish the three studies.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.